The FDA label also includes warnings about fluid retention (which can cause edema, joint pain, and carpal tunnel syndrome), glucose intolerance or diabetes, elevated IGF-1 levels that require monitoring, increased risk of neoplasms or abnormal cell growth (because Tesamorelin stimulates the release of growth hormone, it is contraindicated in patients with active malignancy), hypersensitivity reactions, and increased mortality risk in critically ill patients (a class-effect warning related to growth hormone-releasing products generally)
Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K et al
Emerging research has found new benefits that GLP-1s like Ozempic, Wegovy and Mounjaro may bring to addiction treatment, serious mental illnesses and eating disorders
Stay informed about the medications you are using, and dont hesitate to ask questions if something is unclear
Interested in drinking yerba mate
Circulation Research, 94 (5)